Jupiter Neurosciences Inc (JUNS)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.28+0.61%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · JUNS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | — | 0.0 | — | — | — |
| Total Revenues | — | 0.0 | — | — | — |
| Cost of Revenues | — | 0.0 | — | — | — |
| Gross Profit | — | 0.0 | — | — | — |
| Operating Expenses & Income | |||||
| Selling, General & Admin | — | 6.8 | — | — | — |
| R&D Expenses | 1.9 | 2.1 | 0.5 | 1.0 | — |
| Operating Income | (9.8) | (8.9) | (3.1) | (3.9) | — |
| Earnings from Continuing Operations | |||||
| Interest Expense | — | 0.1 | 0.2 | — | — |
| Interest & Investment Income | — | — | 0.0 | 0.0 | — |
| Other Non-Operating Income / Expenses | 0.6 | 0.3 | 0.7 | (0.9) | — |
| Net Income | |||||
| Net Income | (9.2) | (8.6) | (2.4) | (4.8) | — |
| Per Share | |||||
| Basic EPS | (16.50) | (0.25) | (0.08) | (0.18) | — |
| Diluted EPS | (16.50) | (0.25) | (0.08) | (0.18) | — |
| Basic Weighted Avg Shares | 0.6 | 34.6 | 28.8 | 26.4 | — |
| Diluted Weighted Avg Shares | 0.6 | 34.6 | 28.8 | 26.4 | — |
| Supplemental | |||||
| EBIT | (9.8) | (8.9) | (3.1) | (3.9) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.